Drug maker checks safety of blood thinner in Real-World patients
NCT ID NCT07142655
Summary
This study is monitoring the safety of an approved blood thinner called rivaroxaban in Japanese patients with peripheral artery disease (PAD) who have had leg surgery to improve blood flow. Researchers are reviewing existing medical records of 1,500 patients to track serious bleeding events and heart-related deaths. The goal is to better understand the drug's safety profile in real-world use, as previous studies included few Japanese participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE (PAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical Data Vision Co., Ltd
Tokyo, 101-0053, Japan
Conditions
Explore the condition pages connected to this study.